Congress is considering legislation that would increase patient access to important diagnostic testing services by helping to ensure appropriate reimbursement. IDSA members can help garner support for the bill by using IDSA’s Action Alert
to urge congressional Representatives to co-sponsor it.
In a letter to Rep. Peter Roskam (R- IL), IDSA President Barbara Murray, MD, FIDSA, expressed the Society’s support for the bill, known as the Diagnostic Innovation Testing and Knowledge Advancement Act, which he introduced last year.
Medicare’s appropriate valuation of diagnostic tests is needed to spur innovation and integration into clinical care. The letter explained that diagnostic tests help guide and improve patient care, and that their appropriate use can improve patient outcomes and reduce health care costs associated with suboptimal treatment. IDSA also expressed its strong support of a provision in the bill that would establish an independent advisory panel to provide expert input into rate setting and consideration of patient value and potential impact on health as criteria for use in a new payment setting process.
IDSA’s work on this legislation is one of several current efforts to promote improved diagnostics, a high priority for the Society. Last November, IDSA released “Better Tests, Better Care: Improved Diagnostics for Infectious Diseases,”
a special policy report in Clinical Infectious Diseases, which outlined specific recommendations to spur the development of new diagnostics and encourage their use in patient care and public health.
< Previous Article | Next Article >